Back to Trades
Other4
Outlook Therapeutics, Inc.
OTLK
Total Value
$354.7K
Company Information
- Company Name
- Outlook Therapeutics, Inc.
- Ticker Symbol
- OTLK
- CIK
- 0001649989
Insider Information
- Name
- Huang Andong
- Role
- Director
- Location
- ISELIN, NJ
Director
Filing Details
- Filing Date
- Oct 3, 2025
- Transaction Date
- Oct 1, 2025
- Accession Number
- 0001649989-25-000010
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Oct 1, 2025 | Derivative | 286,734 | $1.04 | Grant/Award | $298.2K |
| Oct 3, 2025 | Derivative | 53,316 | $1.06 | Grant/Award | $56.5K |
Footnotes
- (F1)This option grant is an annual stock option grant under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "2024 Plan") and shall fully vest on October 1, 2026, subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2024 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control.
- (F2)The options were granted under the 2024 Plan in lieu of $50,000 cash fees payable under the Issuer's Non-Employee Director Compensation Policy and vest in four equal quarterly installments on the last day of each fiscal quarter such that they are vested in full on September 30, 2026, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2024 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control.